Preventive approach for overcoming dementia

[1]  Myriam Peyrounette,et al.  Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models , 2018, Nature Neuroscience.

[2]  Stuart T. Smith,et al.  A group study on the effects of a short multi-domain cognitive training in healthy elderly Italian people , 2018, BMC Geriatrics.

[3]  Jinhee Kim,et al.  Association Between Social Support and Health of Aging Adults with Dementia , 2018, Ageing International.

[4]  Lina Ma,et al.  Social Frailty is Associated with Physical Functioning, Cognition, and Depression, and Predicts Mortality , 2018, The journal of nutrition, health & aging.

[5]  Evren Erzen,et al.  The effect of loneliness on depression: A meta-analysis , 2018, The International journal of social psychiatry.

[6]  Yifeng Du,et al.  Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer’s disease , 2018, Neuroscience Letters.

[7]  J. Holt-Lunstad,et al.  Why Social Relationships Are Important for Physical Health: A Systems Approach to Understanding and Modifying Risk and Protection , 2018, Annual review of psychology.

[8]  K. Blennow,et al.  24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial , 2017, The Lancet Neurology.

[9]  K. Kondo,et al.  Influence of social relationship domains and their combinations on incident dementia: a prospective cohort study , 2017, Journal of Epidemiology & Community Health.

[10]  D. Jacobs,et al.  Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2017, The American journal of clinical nutrition.

[11]  T. Kanekiyo,et al.  Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease , 2017, International journal of molecular sciences.

[12]  M. Orrell,et al.  Loneliness, Social Integration, and Incident Dementia Over 6 Years: Prospective Findings From the English Longitudinal Study of Ageing , 2017, The journals of gerontology. Series B, Psychological sciences and social sciences.

[13]  Dev Mehta,et al.  Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 , 2017, Expert opinion on investigational drugs.

[14]  X. Navarro,et al.  Neuroprotective Effects of Exercise Treatments After Injury : The Dual Role of Neurotrophic Factors , 2017 .

[15]  M. Costanzi,et al.  The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age , 2017, Current neuropharmacology.

[16]  S. Lehéricy,et al.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.

[17]  E. Ferriolli,et al.  Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study , 2017, NeuroImage: Clinical.

[18]  N. Hawkes.  Merck ends trial of potential Alzheimer’s drug verubecestat , 2017, British Medical Journal.

[19]  B. Winblad,et al.  The worldwide costs of dementia 2015 and comparisons with 2010 , 2017, Alzheimer's & Dementia.

[20]  A. Flöel,et al.  Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial , 2017, The Journal of Prevention of Alzheimer's Disease.

[21]  Keith A. Johnson,et al.  Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. , 2016, JAMA psychiatry.

[22]  Ryusuke Takechi,et al.  Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective , 2016, Nutrients.

[23]  N. Hawkes.  Promise of new Alzheimer’s drug is dashed after lack of evidence , 2016, British Medical Journal.

[24]  T. Elbert,et al.  Cognitive change is more positively associated with an active lifestyle than with training interventions in older adults at risk of dementia: a controlled interventional clinical trial , 2016, BMC Psychiatry.

[25]  Edo Richard,et al.  Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial , 2016, The Lancet.

[26]  Sheung-Tak Cheng.  Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities , 2016, Current Psychiatry Reports.

[27]  Jeffrey S. Spence,et al.  Distinct Brain and Behavioral Benefits from Cognitive vs. Physical Training: A Randomized Trial in Aging Adults , 2016, Front. Hum. Neurosci..

[28]  R. Ossenkoppele,et al.  The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials , 2016, Ageing Research Reviews.

[29]  R. Marioni,et al.  Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study , 2015, BMC Public Health.

[30]  F. Sacks,et al.  MIND diet associated with reduced incidence of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[31]  N. Smidt,et al.  Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies , 2015, Ageing Research Reviews.

[32]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[33]  Simon C. Dyall,et al.  Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA , 2015, Front. Aging Neurosci..

[34]  Nitish Thakor,et al.  Brain enhancement through cognitive training: a new insight from brain connectome , 2015, Front. Syst. Neurosci..

[35]  Jeffrey S. Spence,et al.  Neural Mechanisms of Brain Plasticity with Complex Cognitive Training in Healthy Seniors , 2013, Cerebral cortex.

[36]  J. Luo,et al.  Hyperhomocysteinemia and Neurologic Disorders: a Review , 2014, Journal of clinical neurology.

[37]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[38]  M. Weiner,et al.  MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA. , 2014, The journal of prevention of Alzheimer's disease.

[39]  Reisa A. Sperling,et al.  Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease , 2014, Science Translational Medicine.

[40]  George W Rebok,et al.  Ten‐Year Effects of the Advanced Cognitive Training for Independent and Vital Elderly Cognitive Training Trial on Cognition and Everyday Functioning in Older Adults , 2014, Journal of the American Geriatrics Society.

[41]  B. Lu,et al.  BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.

[42]  David A. Bennett,et al.  Life-span cognitive activity, neuropathologic burden, and cognitive aging , 2013, Neurology.

[43]  L. Riby,et al.  B Vitamins and Cognitive Performance in Older Adults: Review , 2013, ISRN nutrition.

[44]  Daniel M. Curlik,et al.  Training your brain: Do mental and physical (MAP) training enhance cognition through the process of neurogenesis in the hippocampus? , 2013, Neuropharmacology.

[45]  M. S. Morris.  The role of B vitamins in preventing and treating cognitive impairment and decline. , 2012, Advances in nutrition.

[46]  B. Caffo,et al.  Association of Social Engagement with Brain Volumes Assessed by Structural MRI , 2012, Journal of aging research.

[47]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[48]  Danielle Swanson,et al.  Omega-3 fatty acids EPA and DHA: health benefits throughout life. , 2012, Advances in nutrition.

[49]  F. Schena,et al.  Six-Month Walking Program Changes Cognitive and ADL Performance in Patients With Alzheimer , 2011, American journal of Alzheimer's disease and other dementias.

[50]  G. Lippens,et al.  Oleuropein and derivatives from olives as Tau aggregation inhibitors , 2011, Neurochemistry International.

[51]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[52]  V. Pankratz,et al.  Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study. , 2011, The Journal of neuropsychiatry and clinical neurosciences.

[53]  A. Palmer,et al.  Neuroprotective therapeutics for Alzheimer's disease: progress and prospects. , 2011, Trends in pharmacological sciences.

[54]  I. Rosenberg,et al.  B vitamins and the aging brain. , 2010, Nutrition reviews.

[55]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[56]  A. Hofman,et al.  Dietary antioxidants and long-term risk of dementia. , 2010, Archives of neurology.

[57]  G. Cole,et al.  DHA may prevent age-related dementia. , 2010, The Journal of nutrition.

[58]  D. Galimberti,et al.  Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches. , 2010, Current aging science.

[59]  J. Dartigues,et al.  Leisure activities and the risk of dementia in the elderly , 2007 .

[60]  P. Kris-Etherton,et al.  Dietary reference intakes for DHA and EPA. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[61]  R. Uauy,et al.  Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study , 2009, The American journal of clinical nutrition.

[62]  R. Mayeux,et al.  Mediterranean diet and mild cognitive impairment. , 2009, Archives of neurology.

[63]  J. Zoladz,et al.  Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[64]  R. Mayeux,et al.  Higher folate intake is related to lower risk of Alzheimer’s disease in the elderly , 2008, The journal of nutrition, health & aging.

[65]  Ramon Diaz-Arrastia,et al.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. , 2008, JAMA.

[66]  R. Martins,et al.  Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. , 2008, Advanced drug delivery reviews.

[67]  J. Foster,et al.  Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. , 2008, JAMA.

[68]  R. Hansen,et al.  Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis , 2008, Clinical interventions in aging.

[69]  G. Münch,et al.  Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. , 2007, Journal of neural transmission. Supplementum.

[70]  Yaakov Stern,et al.  Mediterranean diet and risk for Alzheimer's disease , 2006, Annals of neurology.

[71]  J. Schneider,et al.  The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study , 2006, The Lancet Neurology.

[72]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[73]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[74]  R J Harvey,et al.  Donepezil for dementia due to Alzheimer's disease. , 2006, The Cochrane database of systematic reviews.

[75]  Ming-Jang Chiu,et al.  Behavioral and psychologic symptoms in different types of dementia. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

[76]  Malcolm A Binns,et al.  A randomized, crossover trial of high-carbohydrate foods in nursing home residents with Alzheimer's disease: associations among intervention response, body mass index, and behavioral and cognitive function. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[77]  Victoria M Perreau,et al.  Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[78]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[79]  D. Bennett,et al.  Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[80]  S. Henderson,et al.  High carbohydrate diets and Alzheimer's disease. , 2004, Medical hypotheses.

[81]  M. Reger,et al.  Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. , 2004, Neurobiology of aging.

[82]  G. Alexopoulos.  Vascular Disease, Depression, and Dementia , 2003, Journal of the American Geriatrics Society.

[83]  R. Davidson,et al.  Depression: perspectives from affective neuroscience. , 2002, Annual review of psychology.

[84]  J. Lindsay,et al.  Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.

[85]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[86]  R. G. Morris.  D.O. Hebb: The Organization of Behavior, Wiley: New York; 1949 , 1999, Brain Research Bulletin.

[87]  M. Orrell,et al.  Antioxidants and dementia , 1997, The Lancet.

[88]  C. Behl.  Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. , 1997, Cell and tissue research.

[89]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[90]  E. Jones,et al.  Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease , 1994, Neuroscience.

[91]  J. Growdon,et al.  Treatment for Alzheimer's disease? , 1992, The New England journal of medicine.